Evaluation of immunization status in patients with cerebral palsy: a multicenter CP-VACC study
Tóm tắt
Children with chronic neurological diseases, including cerebral palsy (CP), are especially susceptible to vaccine-preventable infections and face an increased risk of severe respiratory infections and decompensation of their disease. This study aims to examine age-appropriate immunization status and related factors in the CP population of our country. This cross-sectional prospective multicentered survey study included 18 pediatric neurology clinics around Turkey, wherein outpatient children with CP were included in the study. Data on patient and CP characteristics, concomitant disorders, vaccination status included in the National Immunization Program (NIP), administration, and influenza vaccine recommendation were collected at a single visit. A total of 1194 patients were enrolled. Regarding immunization records, the most frequently administrated and schedule completed vaccines were BCG (90.8%), hepatitis B (88.9%), and oral poliovirus vaccine (88.5%). MMR was administered to 77.3%, and DTaP-IPV-HiB was administered to 60.5% of patients. For the pneumococcal vaccines, 54.1% of children received PCV in the scope of the NIP, and 15.2% of children were not fully vaccinated for their age. The influenza vaccine was administered only to 3.4% of the patients at any time and was never recommended to 1122 parents (93.9%). In the patients with severe (grades 4 and 5) motor dysfunction, the frequency of incomplete/none vaccination of hepatitis B, BCG, DTaP-IPV-HiB, OPV, and MMR was statistically more common than mild to moderate (grades 1–3) motor dysfunction (p = 0.003, p < 0.001, p < 0.001, p < 0.00, and p < 0.001, respectively). Physicians’ influenza vaccine recommendation was higher in the severe motor dysfunction group, and the difference was statistically significant (p = 0.029). Conclusion: Children with CP had lower immunization rates and incomplete immunization programs. Clinicians must ensure children with CP receive the same preventative health measures as healthy children, including vaccines.
Tài liệu tham khảo
Havers F, Fry AM, Chen J et al (2016) Hospitalizations attributable to respiratory ınfections among children with neurologic disorders. J Pediatr 170:135–141. https://doi.org/10.1016/j.jpeds.2015.11.030
Campbell AJP, Grohskopf LA (2018) Updates on ınfluenza vaccination in children. Infect Dis Clin North Am 32(1):75–89
Pandolfi E, Graziani MC, Ieraci R et al (2008) A comparison of populations vaccinated in a public service and in a private hospital setting in the same area. BMC Public Health 8:278
Tillmann BU, Tillmann HC, Heininger U et al (2005) Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. Eur J Pediatr 164(5):320–325
Dinleyici M, Carman KB, Kilic O et al (2018) The immunization status of children with chronic neurological disease and serological assessment of vaccine-preventable diseases. Hum Vaccin Immunother 14(8):1970–1976
Gasparini R, Panatto D, Lai PL et al (2015) The “urban myth” of the association between neurological disorders and vaccinations. J Prev Med Hyg 56(1):1–8
Rosenbaum P, Paneth N, Leviton A et al (2007) A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 49:8–14
Palisano R, Rosenbaum P, Walter S et al (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39:214–223
Tervo RC, Taylor B (1982) Vaccinations and the physically handicapped child. CMAJ 127:475–477
Ministry of Health (2019) Health Statistics Yearbook 2018. https://dosyasb.saglik.gov.tr/Eklenti/36164,siy2018en2pdf.pdf. Accessed 12 May 2021
Greenwood VJ, Crawford NW, Walstab JE et al (2013) Immunisation coverage in children with cerebral palsy compared with the general population. J Paediatr Child Health 49(2):137–141
Blair E, Langdon K, McIntyre S et al (2019) Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index. BMC Neurol 19(1):111
WHO (2020) Turkey: WHO and UNICEF estimates of immunization coverage: 2019 revision. https://www.who.int/immunization/monitoring_surveillance/data/tur.pdf. Accessed 11 May 2020
CDC (2020) Prevention and control of seasonal ınfluenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States 2020–21 Summary of Recommendations. https://www.cdc.gov/flu/professionals/acip/summary/summary-recommendations.htm. Accessed 11 May 2020
Keren R, Zaoutis TE, Bridges CB et al (2005) Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 294(17):2188–2194
Wong KK, Jain S, Blanton L et al (2013) Influenza-associated pediatric deaths in the United States 2004–2012. Pediatrics 132(5):796–804
Gill PJ, Ashdown HF, Wang K et al (2015) Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis. Lancet Respir Med 3(2):139–149
Pandolfi E, Carloni E, Marino MG et al (2012) Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine 30(34):5172–5178
Havers FP, Fry AM, Peacock G et al (2018) Influenza vaccination coverage in children with neurologic disorders and their siblings July 2006 to June 2014. Pediatr Infect Dis J 37(8):814–816
Bax M, Goldstein M, Rosenbaum P et al (2005) Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 47(8):571–576
Serdaroğlu A, Cansu A, Ozkan S et al (2006) Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol 48(6):413–416